Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Scheinberg P et al. – The findings define the immunological factors that influence the successful adoptive transfer of antigen–specific T–cell immunity during HSCT, which enables the identification of recipients at particular risk of CMV reactivation post–HSCT.
Related Articles
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: Eighty-month follow-up
Bone Marrow Transplantation, 11/13/09
Relevance Score: 83%
Successful Immunotherapy of HCMV Disease Using Virus-Specific T Cells Expanded from an Allogeneic Stem Cell Transplant Recipient
American Journal of Transplantation, 11/18/09
Relevance Score: 82%
Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF-[beta]-Producing CD8+ Treg Cells Are Associated with Immunological Remission of Lupus
Journal of Immunology, 11/10/09
Relevance Score: 82%
Natural killer cells - new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation
Internal Medicine Journal, 10/21/09
Relevance Score: 82%
History of cord blood transplantation
Bone Marrow Transplantation, 10/07/09
Relevance Score: 82%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring
Bone Marrow Transplantation, 12/10/09
A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT
Bone Marrow Transplantation, 12/10/09
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
Bone Marrow Transplantation, 12/10/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
British Journal of Cancer, 12/11/09
Relationship between topoisomerase 2A RNA expression and recurrence after adjuvant chemotherapy for breast cancer
Clinical Cancer Research, 12/11/09
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers
Journal of Clinical Oncology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


